PHIL Inc. has partnered with Harrow to launch HarrowRx, a single prescribing destination for Harrow’s ophthalmic treatment portfolio. This state-of-the-art platform utilizes existing electronic medical records to help eye care providers offer advanced patient services and more seamless care.
PHIL Partners with Harrow to Power HarrowRx, One Prescribing Destination for Harrow’s Eye Care Portfolio
Key Takeaways:
• A single platform, HarrowRx, is now available for e-prescribing Harrow’s eye care treatments.
• PHIL Inc. is recognized as a technology-powered patient access platform.
• Harrow is a leading provider of ophthalmic disease management solutions in North America (Nasdaq: HROW).
• HarrowRx integrates seamlessly with existing EMR systems, improving efficiency for eye care professionals.
• Built-in patient services and ECP support are key features of HarrowRx, potentially boosting patient satisfaction.
The Partnership and Its Purpose
PHIL Inc., a technology-powered patient access platform, has formed a new collaboration with Harrow, a leading provider of ophthalmic disease management solutions in North America. Announced on November 2, 2026, the partnership centers on launching HarrowRx, a recently developed prescribing and access platform.
PHIL’s Role
PHIL Inc. offers technology solutions designed to make healthcare more accessible to patients. By bringing their expertise in patient access to this collaboration, PHIL will help ensure that HarrowRx is integrated smoothly into the standard workflows of eye care professionals.
Harrow’s Expertise in Ophthalmic Care
Harrow (Nasdaq: HROW) is widely recognized for its focus on creating solutions to address a range of conditions affecting patients’ eye health. This expertise gives HarrowRx a unique advantage in meeting providers’ need for an integrated, comprehensive platform for prescribing ophthalmic treatments.
Introducing HarrowRx
The newly launched HarrowRx solution consolidates Harrow’s branded ophthalmic offerings. It is designed to serve as a single, user-friendly interface where doctors can electronically prescribe medications and manage patient access. By offering a unified platform, HarrowRx seeks to simplify the process for both providers and patients.
Seamless EMR Integration
One of the central features of HarrowRx is its ability to integrate directly with existing electronic medical record (EMR) systems. Through this setup, eye care professionals can quickly write and manage prescriptions without switching between multiple platforms, potentially reducing administrative burdens and speeding up treatment times.
Built-in Patient Services and ECP Support
HarrowRx includes a set of built-in patient support tools, ensuring that individuals receive the appropriate care and follow-up assistance. Eye care providers can also benefit from dedicated ECP support, streamlining their workflow and fostering a more efficient connection with lab services, pharmacies, and other partners in patient care.
With HarrowRx, both PHIL and Harrow seek to improve the overall eye care experience by simplifying prescription workflows and enhancing patient service. By offering all of Harrow’s branded ophthalmic products on a single, integrated platform, the initiative could help shape the future of efficient, technology-driven vision care.